The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
 
Amikar Sehdev
Consulting or Advisory Role - Gerson Lehrman Group
 
Yuanyuan Zha
No Relationships to Disclose
 
Theodore G. Karrison
No Relationships to Disclose
 
Linda A. Janisch
No Relationships to Disclose
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Human Longevity, Inc; Merck; Pfizer
Speakers' Bureau - Bayer; Eisai
 
Michael L. Maitland
Consulting or Advisory Role - Bayer (I); Gilead Sciences (I); Merck Sharp & Dohme (I)
 
Blase N. Polite
Consulting or Advisory Role - AstraZeneca; Pfizer
Speakers' Bureau - Bayer/Onyx
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Michelle Turcich
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris
 
Ravi Salgia
No Relationships to Disclose
 
Navin R. Pinto
No Relationships to Disclose
 
Thomas Gajewski
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; FORMA Therapeutics; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Evelo (Inst)
 
Marc Bissonnette
No Relationships to Disclose
 
Mark J. Ratain
Stock and Other Ownership Interests - Biscayne Pharmaceuticals; PrescriptIQ; Venaxis
Consulting or Advisory Role - AbbVie; Amgen; Biomarin; Biscayne Pharmaceuticals; Circle Pharma; Cyclacel; Drais Pharmaceuticals; Genentech/Roche; Portola Pharmaceuticals; Shionogi; Venaxis
Research Funding - Dicerna (Inst); OncoTherapy Science (Inst)
Patents, Royalties, Other Intellectual Property - pending patent related to a genomic prescribing system; pending patent related to a genomic prescribing system (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - multiple generic companies
 
Manish Sharma
Consulting or Advisory Role - Bayer; EMD Serono; Ipsen